Hologic, Inc.は、4.5%の収益増加を報告した後、投資の増加と株価の格上げが見られました。 Hologic, Inc. saw increased investments and a stock upgrade after reporting a 4.5% revenue rise.

バークレーズと他のヘッジファンドは,Hologic, Inc.の株価を増加させ,Hologicは第3四半期にEPS1.01ドルと9億8,790万ドルの収益を報告し,前年比4.5%増加しました. Barclays and other hedge funds increased their stakes in Hologic, Inc., which reported $1.01 EPS and $987.90 million in revenue for the third quarter, up 4.5% year-over-year. 分析者は,今年4.28のEPSを予測しています. Analysts predict an EPS of 4.28 for the current year. 株価は"強買い"にアップグレードされ 総評は"適度買い"で 目標価格は89.50ドルです BNP Paribas upgraded the stock to "strong-buy," and the consensus rating is "Moderate Buy" with a target price of $89.50. Hologicの時価総額は170億4000万ドルです。 Hologic's market cap is $17.04 billion.